⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL800658 | 0.72 | — | — | |
| SCHEMBL16079074 | 0.69 | — | — | |
| SCHEMBL12556981 | 0.67 | — | — | |
| SCHEMBL19199804 | 0.67 | — | — | |
| SCHEMBL6767753 | 0.65 | — | — | |
| SCHEMBL14498529 | 0.65 | — | — | |
| SCHEMBL28149540 | 0.63 | — | — | |
| SCHEMBL16109644 | 0.63 | — | — | |
| Hydrochloric Acid SCHEMBL28931785 | 0.62 | — | — | |
| SCHEMBL16325453 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183613-A2 | INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR INFLAMMATION | TACTOGEN INC (US) | 2023-09-28 | — | — | WO | disclosed |
| WO-2022078152-A1 | BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF | 杭州中美华东制药有限公司 | 2022-04-21 | — | — | WO | disclosed |